Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Shares Outstanding data on record, last reported at $15.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 148.91% year-over-year to $15.8 million; the TTM value through Sep 2025 reached $15.8 million, up 148.91%, while the annual FY2024 figure was $7.5 million, 36.01% up from the prior year.
  • Shares Outstanding reached $15.8 million in Q3 2025 per ASMB's latest filing, up from $7.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $52.0 million in Q1 2023 and bottomed at $4.0 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $21.4 million, with a median of $7.6 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding: plummeted 90.99% in 2023, then surged 148.91% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $4.0 million in 2021, then grew by 1.61% to $4.1 million in 2022, then skyrocketed by 34.56% to $5.5 million in 2023, then surged by 36.01% to $7.5 million in 2024, then skyrocketed by 112.1% to $15.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $15.8 million in Q3 2025, $7.7 million in Q2 2025, and $7.6 million in Q1 2025.